Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Sandor Steven

2. Date of Event Requiring Statement (MM/DD/YYYY) 7/6/2022

3. Issuer Name and Ticker or Trading Symbol

BIOLASE, INC [BIOL]

(Last) (First) (Middle)

27042 TOWNE CENTRE DRIVE, SUITE 270

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
Chief Operating Officer /

(Street)

FOOTHILL RANCH, CA 92610

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2355	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Unit	⁽¹⁾	⁽¹⁾	Common Stock	200	⁽²⁾	D
Restricted Stock Unit	⁽³⁾	⁽³⁾	Common Stock	1800	⁽²⁾	D
Restricted Stock Unit	⁽⁴⁾	⁽⁴⁾	Common Stock	450	⁽²⁾	D
Restricted Stock Unit	⁽⁵⁾	⁽⁵⁾	Common Stock	8544	⁽²⁾	D
Stock Option (right to buy)	⁽⁶⁾	4/8/2029	Common Stock	800	$52.75	D

Explanation of Responses:
(1)	The restricted stock unit award vests as to 200 shares on April 8, 2023, subject to the Reporting Person's continued service with the Company.
(2)	At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent.
(3)	The restricted stock unit award vests as to 900 shares on each of August 10, 2022 and August 10, 2023, subject to the Reporting Person's continued service with the Company.
(4)	The restricted stock unit award vests as to 450 shares on August 5, 2022, subject to the Reporting Person's continued service with the Company.
(5)	The restricted stock unit award vests in accordance with performance criteria established by the Compensation Committee of the Company, subject to the Reporting Person's continued service with the Company.
(6)	The stock option vests immediately as to 201 shares, and the remainder vests ratably over a 36-month period, commencing on May 8, 2020, subject to the Reporting Person's continued service with the Company.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Sandor Steven 27042 TOWNE CENTRE DRIVE SUITE 270 FOOTHILL RANCH, CA 92610			Chief Operating Officer

Signatures
/s/ Michael C. Carroll, attorney-in-fact for Steven Sandor		7/14/2022
^**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.